<DOC>
	<DOCNO>NCT01574508</DOCNO>
	<brief_summary>The current study compare different efficacy two transient intensive insulin treatment strategy : Continuous subcutaneous insulin infusion ( CSII ) multiple daily insulin injection ( MDI ) patient well controlled oral hypoglycaemic agent .</brief_summary>
	<brief_title>Continuous Subcutaneous Insulin Infusion strAtegy Versus Multiple Daily Insulin Injections strAtegy</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Using least two kind oral hypoglycaemic agent , one must insulin secretagogues ( least half maximum permitted daily dose ) ; least two kind oral hypoglycaemic agent , one must insulin secretagogues ( least half maximum permitted daily dose ) , plus daily basic insulin treatment ( daily dosage &lt; 30IU ) ; 2 . The antidiabetic therapy stable within 3 month study screen ; 3 . Age : 2565years , gender , BMI : 2035kg/m2 ; 4 . Good compliance followup 5 . Signed informed consent 6 . HbA1c ≥ 8.0 % ≤ 12 % 1 . Having history use insulin therapy twice daily MDI insulin pump ( except insulin therapy gestational diabetes mellitus ) 2 . For daily insulin therapy : daily dose insulin therapy dosage &gt; 30IU 3 . Having history use GLP1 therapy within 3 month screen 4 . Women pregnancy breast feed 5 . Having acute diabetic complication within 6 month screen severe chronic diabetic complication screen 6 . Allergic study drug 7 . Severe liver dysfunction , include serum alanine aminotransferase concentration 2.5 time upper limit normal range , abnormal renal function ( GFR &lt; 60ml/min ) 8 . Other severe condition put patient high risk study 9 . Recently drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
	<keyword>intensive insulin therapy</keyword>
</DOC>